Treating a risk factor as a cause
A risk factor raises the likelihood of a disorder. Many people with a risk factor never develop one, and most disorders involve several factors interacting. Write "increases the risk of", not "causes".
Psychology · Unit 2 · Topic 3
Why psychological disorders develop, seen through the biopsychosocial approach: risk factors, anxiety disorders, stigma, the treatments and how trials test them, the placebo effect, and prevalence across cultures.
Describe how biological, psychological and social factors act together in psychological disorder, and why the approach draws on psychology, psychiatry and social work.
Classify risk factors for psychological disorder as biological, psychological or social, using the syllabus's examples, and explain how they combine and interact.
Describe how common anxiety disorders are, and the symptoms of generalised anxiety disorder and specific phobias as the DSM-5-TR (2022) describes them.
Explain the biological, psychological and social factors thought to contribute to GAD and specific phobias, including how a phobia can be learnt and kept going.
Describe public stigma and self-stigma and explain, with evidence, how stigma reduces help-seeking for psychological disorders and what increases it.
Compare psychotherapies, pharmacotherapies, electroconvulsive therapy (ECT) and psychosurgery on how they work, what they treat, their evidence, side effects and reversibility.
Explain the placebo effect, and why treatment trials use a placebo group, random allocation and single-blind or double-blind procedures.
Analyse a three-group placebo-controlled trial, calculating means, standard deviations and the placebo and treatment effects, reading error bars, and drawing conclusions from t-tests.
Analyse prevalence data from different cultures, calculating from tables and explaining differences as real differences or as differences in reporting, stigma and diagnostic practice.
Describe how psychological disorders affect individuals, families and communities, how the focus has shifted to psychological health, and evaluate support interventions for each.
Ten questions across the topic, from foundation to complex unfamiliar. Your results feed your mastery.
Most people know someone who has lived with anxiety or depression, and in Australia about two in five adults have had a mental disorder at some point in their life. This topic asks why disorders develop, how they are treated, and how psychologists know whether a treatment works.
You start with the biopsychosocial approach, which looks at a disorder through biological, psychological and social factors at once, and you classify risk factors the way the syllabus does. Then you study the anxiety disorders, generalised anxiety disorder (GAD) and specific phobias: how common they are, their symptoms and their perceived causes, and how stigma keeps people from seeking help.
Next come the treatments, from psychotherapies and pharmacotherapies to electroconvulsive therapy (ECT) and psychosurgery, and the research that tests them. The placebo effect is why a treatment trial needs a placebo group and blinding, and you will analyse a trial's data with means, standard deviations, error bars and a t-test. Finally you read prevalence tables from different cultures, and weigh how much of a difference is real and how much comes from reporting, stigma and diagnostic practice, before looking at the support that helps people, their families and their communities.
Units 1 and 2 are assessed by your school. Expect short-response questions on risk factors, symptoms and treatments, data questions on trials and prevalence tables, and extended responses that compare treatments or evaluate support.
Builds on Diagnosis.
Subject matter from the Psychology General senior syllabus 2025 v1.3 (opens in a new tab), CC BY 4.0 © State of Queensland (QCAA).
The focus areas you can practise on their own. Each one maps to dot points above.
The biopsychosocial approach
Describe how biological, psychological and social factors interact in psychological disorder, and which professions contribute evidence.
Classifying risk factors
Classify risk factors as biological, psychological or social using the syllabus's examples, and explain how they interact.
GAD and specific phobias
Describe the prevalence, symptoms and perceived causes of generalised anxiety disorder and specific phobias.
Stigma and help-seeking
Distinguish public stigma and self-stigma and describe how stigma reduces help-seeking, with evidence.
Comparing treatments
Compare psychotherapies, pharmacotherapies, ECT and psychosurgery on how they work, what they treat, their evidence and their risks.
The placebo effect
Explain the placebo effect and why trials use placebo groups, single-blind and double-blind procedures.
Analysing treatment trials
Calculate means, standard deviations, standard errors and effects from trial data, read error bars, and interpret t-tests and p-values.
Designing treatment trials
Identify variables, controls, allocation and ethical issues in a treatment trial, and suggest improvements.
Prevalence across cultures
Read and calculate from prevalence tables, and explain differences between cultures as real differences or as reporting, stigma and diagnostic practice.
Support and psychological health
Describe the impact of disorder on individuals, families and communities, and evaluate support interventions for each.
A risk factor raises the likelihood of a disorder. Many people with a risk factor never develop one, and most disorders involve several factors interacting. Write "increases the risk of", not "causes".
The syllabus classifies stress as a psychological risk factor (how a person appraises and copes with demands), even though its triggers may be social. Sleep, medication and substance use are biological; significant relationships and disorganised attachment are social.
GAD is worry about many everyday things, most days, for at least six months. A specific phobia is intense fear of one object or situation, out of proportion to the danger, that the person avoids.
The improvement is real and measurable; what is missing is an active ingredient. The cause is the person's expectation of benefit (and the attention and care of treatment).
The difference between the drug group and the no-treatment group includes the placebo effect. The drug's own effect is treatment minus placebo.
Single-blind: the participants don't know their condition. Double-blind: neither the participants nor the researchers running and scoring them know. Double-blind also controls experimenter expectancy.
ECT produces a brief seizure and destroys no tissue; its effects on mood (and memory) are not permanent damage. Psychosurgery destroys or removes brain tissue and is irreversible.
A lower measured prevalence can mean fewer people have the disorder, or that fewer report it (stigma), the survey questions fit the culture less well, or clinicians diagnose it differently. Say which explanations the data can and cannot rule out.
Lifetime prevalence is always at least as high as 12-month prevalence for the same disorder. Check the period in the table heading before comparing two figures.
In "classify" questions, name the domain and the syllabus example it matches: "poor sleep is a biological risk factor (sleep)".
When you describe the biopsychosocial approach, show the factors interacting: one factor makes another more likely (poor sleep increases rumination, which disturbs sleep further).
For "compare" questions on treatments, use the same criteria for each treatment (how it works, what it treats, evidence, side effects, invasiveness and reversibility) and finish with a similarity and a difference.
In a trial, the placebo effect is placebo minus no treatment and the treatment effect is treatment minus placebo. Show the subtraction and the units.
State a conclusion from a t-test in three parts: the p-value compared with 0.05, reject or retain the null hypothesis, and what that means for the treatment in the words of the question.
When prevalence differs between cultures, give at least one explanation that is a real difference and at least one that is a measurement difference (reporting, stigma, diagnostic practice), and say what further data would tell them apart.
Use person-first language in every answer: "a person with GAD", not "a GAD sufferer" or "an anxious person".
Mental health services in Australia, such as headspace centres for 12 to 25 year olds and GP mental health treatment plans, are built on the biopsychosocial approach: they combine medical, psychological and social support.
Every new medication approved for a psychological disorder has been tested in randomised, double-blind, placebo-controlled trials like the ones you analyse here.
Anti-stigma campaigns and mental health literacy programs aim to increase help-seeking, especially among young people and men.
Cross-cultural prevalence surveys, such as the WHO World Mental Health Surveys, guide where health systems put their resources.
Workplaces and schools use the shift towards psychological health (wellbeing programs, mental health first aid training) to support people before a disorder develops.